Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,704 public trials 1,044 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, Tolerability and Antitumor Activity of Selinexor Combination Treatment

NCT04256707

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations
  • Hadassah Ein Karem University Hospital Jerusalem, Israel
  • University Hospital Assuta Ashdod Ashdod, Israel
  • Soroka University Medical Center Beersheba, Israel
  • Oncology Department Hillel Yaffe Medical Center Hadera, Israel
View Trial Details
Completed

RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

NCT02489903

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, +31 more
Locations
  • Stanford University Palo Alto, California, United States
  • VA Connecticut Cancer Center West Haven, Connecticut, United States
  • Memorial Hospital of South Bend South Bend, Indiana, United States
  • Baptist Health Lexington, Kentucky, United States
View Trial Details
Completed

An Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma

NCT02783300

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +38 more
Locations
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Nashville, Tennessee, United States
View all 15 locations
View Trial Details
Completed

Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFR

NCT00446225

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Centre Hospitalier Universitaire D'Angers Angers, France
  • Hôpital Auguste Morvan Brest, France
  • Centre François Baclesse Caen, France
  • Centre Hospitalier René Dubos Cergy-Pontoise, France
View all 76 locations
View Trial Details
Completed

NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC

NCT04880863

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • NeoTX - 10307 Daphne, Alabama, United States
  • NeoTX - 10302 Scottsdale, Arizona, United States
  • NeoTX - 10303 Tucson, Arizona, United States
  • NeoTX - 10306 Lone Tree, Colorado, United States
View Trial Details
Completed

Erlotinib Hydrochloride and Onalespib Lactate in Treating Patients With Recurrent or Metastatic EGFR-Mutant Non-small Cell Lung Cancer

NCT02535338

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Keck Medical Center of USC Pasadena Pasadena, California, United States
View Trial Details
Completed

The Study Observes Afatinib as First-line Treatment in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Non-small Cell Lung Cancer

NCT04206787

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Peking Union Medical College Hospital Beijing, China
  • West China Hospital Chengdu, China
  • The First Afiliated Hospital, Sun Yet-sen University Guangzhou, China
  • First Affiliated Hospital of Guangzhou Medical University Guangzhou, China
View Trial Details

Related conditions